Russell Investments Group
ONCE

Russell Investments Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Russell Investments Group’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,523
Closed -$2.38M – 3182
2019
Q3 		$2.38M Buy
24,523
+1,543
+7% +$155K ﹤0.01% 1575
2019
Q2 		$2.35M Sell
22,980
-2,795
-11% -$302K ﹤0.01% 1593
2019
Q1 		$2.94M Hold
25,775
– – 0.01% 1520
2018
Q4 		$1.01M Buy
25,775
+1,316
+5% +$57.1K ﹤0.01% 1955
2018
Q3 		$1.33M Buy
24,459
+4,438
+22% +$303K ﹤0.01% 1958
2018
Q2 		$1.66M Buy
20,021
+79
+0.4% +$6.1K ﹤0.01% 1858
2018
Q1 		$1.33M Buy
19,942
+5,969
+43% +$345K ﹤0.01% 2067
2017
Q4 		$728K Sell
13,973
-95,725
-87% -$6.88M ﹤0.01% 2296
2017
Q3 		$9.78M Buy
109,698
+84,470
+335% +$6.41M 0.02% 967
2017
Q2 		$1.51M Buy
25,228
+11,335
+82% +$633K ﹤0.01% 1904
2017
Q1 		$741K Sell
13,893
-3,573
-20% -$212K ﹤0.01% 2260
2016
Q4 		$883K Buy
+17,466
New +$936K ﹤0.01% 2239

Russell Investments Group's ONCE Position: Q4 2019 in Review

Russell Investments Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 24,523 shares — an estimated $2.38M sold.

Russell Investments Group first reported a position in ONCE in Q4 2016 and held it in 12 quarters. The position peaked at $9.78M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Russell Investments Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Russell Investments Group sold 24,523 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.38M.
  • Russell Investments Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2016 and held it in 12 quarters.
  • Russell Investments Group's Spark Therapeutics, Inc. Common Stock position peaked at $9.78M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Russell Investments Group's 13F filing for Q4 2019, filed 29 Jan 2020.